These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38791483)

  • 1. Genome-Wide DNA Methylation in Early-Onset-Dementia Patients Brain Tissue and Lymphoblastoid Cell Lines.
    Ramos-Campoy O; Comas-Albertí A; Hervás D; Borrego-Écija S; Bosch B; Sandoval J; Fort-Aznar L; Moreno-Izco F; Fernández-Villullas G; Molina-Porcel L; Balasa M; Lladó A; Sánchez-Valle R; Antonell A
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Gene Expression in Sporadic and Genetic Forms of Alzheimer's Disease and Frontotemporal Dementia in Brain Tissue and Lymphoblastoid Cell Lines.
    Ramos-Campoy O; Lladó A; Bosch B; Ferrer M; Pérez-Millan A; Vergara M; Molina-Porcel L; Fort-Aznar L; Gonzalo R; Moreno-Izco F; Fernandez-Villullas G; Balasa M; Sánchez-Valle R; Antonell A
    Mol Neurobiol; 2022 Oct; 59(10):6411-6428. PubMed ID: 35962298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease progression.
    Wang Q; Chen Y; Readhead B; Chen K; Su Y; Reiman EM; Dudley JT
    Clin Epigenetics; 2020 Dec; 12(1):189. PubMed ID: 33298155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide DNA methylation analysis reveals hypomethylation in the low-CpG promoter regions in lymphoblastoid cell lines.
    Taniguchi I; Iwaya C; Ohnaka K; Shibata H; Yamamoto K
    Hum Genomics; 2017 May; 11(1):8. PubMed ID: 28499412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated DNA methylation and gene expression profiling across multiple brain regions implicate novel genes in Alzheimer's disease.
    Semick SA; Bharadwaj RA; Collado-Torres L; Tao R; Shin JH; Deep-Soboslay A; Weiss JR; Weinberger DR; Hyde TM; Kleinman JE; Jaffe AE; Mattay VS
    Acta Neuropathol; 2019 Apr; 137(4):557-569. PubMed ID: 30712078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoblastoid cell lines reveal associations of adult DNA methylation with childhood and current adversity that are distinct from whole blood associations.
    Suderman M; Pappas JJ; Borghol N; Buxton JL; McArdle WL; Ring SM; Hertzman C; Power C; Szyf M; Pembrey M
    Int J Epidemiol; 2015 Aug; 44(4):1331-40. PubMed ID: 26351305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative tauopathy.
    Li Y; Chen JA; Sears RL; Gao F; Klein ED; Karydas A; Geschwind MD; Rosen HJ; Boxer AL; Guo W; Pellegrini M; Horvath S; Miller BL; Geschwind DH; Coppola G
    PLoS Genet; 2014 Mar; 10(3):e1004211. PubMed ID: 24603599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole genome methylation sequencing in blood identifies extensive differential DNA methylation in late-onset dementia due to Alzheimer's disease.
    Breen C; Papale LA; Clark LR; Bergmann PE; Madrid A; Asthana S; Johnson SC; Keleş S; Alisch RS; Hogan KJ
    Alzheimers Dement; 2024 Feb; 20(2):1050-1062. PubMed ID: 37856321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide analysis of DNA methylation in an APP/PS1 mouse model of Alzheimer's disease.
    Cong L; Jia J; Qin W; Ren Y; Sun Y
    Acta Neurol Belg; 2014 Sep; 114(3):195-206. PubMed ID: 24347181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of DNA methylation and its association with other biological systems in lymphoblastoid cell lines.
    Zhang Z; Liu J; Kaur M; Krantz ID
    Genomics; 2012 Apr; 99(4):209-19. PubMed ID: 22269447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel profiling of DNA methylation and hydroxymethylation highlights neuropathology-associated epigenetic variation in Alzheimer's disease.
    Smith AR; Smith RG; Pishva E; Hannon E; Roubroeks JAY; Burrage J; Troakes C; Al-Sarraj S; Sloan C; Mill J; van den Hove DL; Lunnon K
    Clin Epigenetics; 2019 Mar; 11(1):52. PubMed ID: 30898171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early epigenetic changes of Alzheimer's disease in the human hippocampus.
    Blanco-Luquin I; Acha B; Urdánoz-Casado A; Sánchez-Ruiz De Gordoa J; Vicuña-Urriza J; Roldán M; Labarga A; Zelaya MV; Cabello C; Méndez-López I; Mendioroz M
    Epigenetics; 2020 Oct; 15(10):1083-1092. PubMed ID: 32233750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex.
    Bakulski KM; Dolinoy DC; Sartor MA; Paulson HL; Konen JR; Lieberman AP; Albin RL; Hu H; Rozek LS
    J Alzheimers Dis; 2012; 29(3):571-88. PubMed ID: 22451312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive DNA methylation analysis of human peripheral blood leukocytes and lymphoblastoid cell lines.
    Sugawara H; Iwamoto K; Bundo M; Ueda J; Ishigooka J; Kato T
    Epigenetics; 2011 Apr; 6(4):508-15. PubMed ID: 21304276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy.
    Chen JA; Wang Q; Davis-Turak J; Li Y; Karydas AM; Hsu SC; Sears RL; Chatzopoulou D; Huang AY; Wojta KJ; Klein E; Lee J; Beekly DL; Boxer A; Faber KM; Haase CM; Miller J; Poon WW; Rosen A; Rosen H; Sapozhnikova A; Shapira J; Varpetian A; Foroud TM; Levenson RW; Levey AI; Kukull WA; Mendez MF; Ringman J; Chui H; Cotman C; DeCarli C; Miller BL; Geschwind DH; Coppola G
    JAMA Neurol; 2015 Apr; 72(4):414-22. PubMed ID: 25706306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Genetics and Epigenetics in the Pathogenesis of Alzheimer's Disease and Frontotemporal Dementia.
    Fenoglio C; Scarpini E; Serpente M; Galimberti D
    J Alzheimers Dis; 2018; 62(3):913-932. PubMed ID: 29562532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroepigenetics: Desoxyribonucleic acid methylation in Alzheimer's disease and other dementias].
    Mendioroz Iriarte M; Pulido Fontes L; Méndez-López I
    Med Clin (Barc); 2015 May; 144(10):457-64. PubMed ID: 24907105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of epigenetic clocks in brain tissue with brain pathologies and common aging phenotypes.
    Grodstein F; Lemos B; Yu L; Klein HU; Iatrou A; Buchman AS; Shireby GL; Mill J; Schneider JA; De Jager PL; Bennett DA
    Neurobiol Dis; 2021 Sep; 157():105428. PubMed ID: 34153464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation signature of human hippocampus in Alzheimer's disease is linked to neurogenesis.
    Altuna M; Urdánoz-Casado A; Sánchez-Ruiz de Gordoa J; Zelaya MV; Labarga A; Lepesant JMJ; Roldán M; Blanco-Luquin I; Perdones Á; Larumbe R; Jericó I; Echavarri C; Méndez-López I; Di Stefano L; Mendioroz M
    Clin Epigenetics; 2019 Jun; 11(1):91. PubMed ID: 31217032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene promoter methylation and expression of Pin1 differ between patients with frontotemporal dementia and Alzheimer's disease.
    Ferri E; Arosio B; D'Addario C; Galimberti D; Gussago C; Pucci M; Casati M; Fenoglio C; Abbate C; Rossi PD; Scarpini E; Maccarrone M; Mari D
    J Neurol Sci; 2016 Mar; 362():283-6. PubMed ID: 26944164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.